Aptevo Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $55.4M | $56.6M | $45.0M |
| FY2022 | $16.2M | $34.2M | $22.6M |
| FY2023 | $12.6M | $24.8M | $16.9M |
| FY2024 | $10.8M | $15.6M | $8.7M |
| FY2025 | $9.8M | $27.2M | $21.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $55.4M | $56.6M | $45.0M |
| FY2022 | $16.2M | $34.2M | $22.6M |
| FY2023 | $12.6M | $24.8M | $16.9M |
| FY2024 | $10.8M | $15.6M | $8.7M |
| FY2025 | $9.8M | $27.2M | $21.6M |